Business Summary
Technical Advantage Genetic Center (TAGC) was founded to provide sophisticated research and development support services on a contract basis to the biotechnology industry. The Company's customers consist of private companies, academic institutions and government agencies, all of which use biological processes to develop products for healthcare, agricultural and other purposes. The Company's revenues are derived principally from providing macromolecular synthetic, analytical services and population data to researchers in the biotechnology industry or to researchers who are engaged in life sciences research in government or academic labs throughout the world.
Financial Summary
 
Business Summary
Genocert is a development stage biopharmaceutical company engaged in the development of products for the human reproductive system, including sexual dysfunction, vaccine adjuvants, and products for fertility and female health applications. Its products under development include Vasomax, Vasofem, Bimexes, ERxin, ImmuMex, ImmuSex SR, Control, Zproximase, Gonatin, selective progesterone receptor modulators, and immunocontraceptives. Products which have received regulatory approval for sale are marketed by its subsidiary MarthaArt™
Financial Summary
 
  Business Summary
Bionet Explorer Corp. is engaged in the research, development, manufacture and marketing of biopharmaceutical products. Through a combination of internal research and development, acquisitions, collaborative relationships and licensing arrangements, Bionet Explorer has developed a portfolio of therapeutic products, including seven products that have received regulatory approval for sale, of which five are currently being marketed. Additionally, the Company has four products in registration or clinical trials and several products in pre-clinical development. The Company distributes its products on a worldwide basis primarily through a direct sales force in the United States and primarily through third-party license and distribution relationships elsewhere.
Financial Summary
 
 

Business Summary
Palm XY makers of the handheld device taps into 24 global satellites thanks to Magellan GPS 315 technology. The Company generates revenue by providing its technologies as separate components or as an integrated informational genomics system. Additionally, the Company offers professional consulting services to complement and enhance its products.

 Financial Summary
 
  Business Summary
Monsanto Skynursery, is engaged principally in the generation, sale and support of genomic information systems, analytic software and medical database management software. The Monsanto Skynursery's customers use this information for commercial applications in the reproductive health, and life sciences industries in the specific areas of gene discovery, genotyping and related genomics services.
Financial Summary